NDC 69315-285-20
ETRAVIRINE 100 mg/1
ETRAVIRINE · TABLET
Etravirine is a prescription tablet taken by mouth to help treat Human Immunodeficiency Virus (HIV) infection by blocking reverse transcriptase, an enzyme the virus needs to replicate. It is typically used as part of a combination antiretroviral therapy regimen for HIV-positive patients.
Key Facts
- Brand Name
- ETRAVIRINE
- Generic Name
- ETRAVIRINE
- NDC Code (Package)
69315-285-20- NDC Code (Product)
69315-285- Manufacturer
- Leading Pharma, LLC
- Strength
- 100 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- ANDA215402
- Drug Class
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 06/05/2022
Recall History
No Recall HistoryView Full Drug Page
ETRAVIRINE — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.